메뉴 건너뛰기




Volumn 30, Issue 13, 2012, Pages 2301-2308

Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis

Author keywords

Baculovirus expression system; Coxsackievirus B3; Vaccine; Virus like particles

Indexed keywords

COXSACKIEVIRUS B3 VIRUS LIKE PARTICLE VACCINE; LIVE VACCINE; SUCROSE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN;

EID: 84862809216     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.061     Document Type: Article
Times cited : (41)

References (51)
  • 1
    • 0033514987 scopus 로고    scopus 로고
    • From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future
    • Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100.
    • (1999) Circulation , vol.99 , pp. 1091-1100
    • Kawai, C.1
  • 2
    • 0036211870 scopus 로고    scopus 로고
    • Pathophysiology of viral myocarditis: the role of humoral immune response
    • Maisch B., Ristić A.D., Hufnagel G., Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002, 11:112-122.
    • (2002) Cardiovasc Pathol , vol.11 , pp. 112-122
    • Maisch, B.1    Ristić, A.D.2    Hufnagel, G.3    Pankuweit, S.4
  • 3
    • 21644483408 scopus 로고    scopus 로고
    • A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection
    • Dan M., Chantler J.K. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J Virol 2005, 79:9285-9295.
    • (2005) J Virol , vol.79 , pp. 9285-9295
    • Dan, M.1    Chantler, J.K.2
  • 4
    • 0027336111 scopus 로고
    • High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis
    • Fohlman J., Pauksen K., Morein B., Bjare U., Ilbäck N.G., Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis Suppl 1993, 88:103-108.
    • (1993) Scand J Infect Dis Suppl , vol.88 , pp. 103-108
    • Fohlman, J.1    Pauksen, K.2    Morein, B.3    Bjare, U.4    Ilbäck, N.G.5    Friman, G.6
  • 5
    • 0031714796 scopus 로고    scopus 로고
    • Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization
    • Henke A., Wagner E., Whitton J.L., Zell R., Stelzner A. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol 1998, 72:8327-8331.
    • (1998) J Virol , vol.72 , pp. 8327-8331
    • Henke, A.1    Wagner, E.2    Whitton, J.L.3    Zell, R.4    Stelzner, A.5
  • 6
    • 0035122776 scopus 로고    scopus 로고
    • DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice
    • Henke A., Zell R., Stelzner A. DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice. Antiviral Res 2001, 49:49-54.
    • (2001) Antiviral Res , vol.49 , pp. 49-54
    • Henke, A.1    Zell, R.2    Stelzner, A.3
  • 7
    • 13444278886 scopus 로고    scopus 로고
    • Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge
    • Kim J.-Y., Jeon E.-S., Lim B.-K., Kim S.-M., Chung S.-K., Kim J.-M., et al. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine 2005, 23:1672-1679.
    • (2005) Vaccine , vol.23 , pp. 1672-1679
    • Kim, J.-Y.1    Jeon, E.-S.2    Lim, B.-K.3    Kim, S.-M.4    Chung, S.-K.5    Kim, J.-M.6
  • 8
    • 0000309474 scopus 로고
    • Proteolytic processing in the replication of picornaviruses
    • Harris K.S., Hellen C.U.T., Wimmer E. Proteolytic processing in the replication of picornaviruses. Semin Virol 1990, 1:323-333.
    • (1990) Semin Virol , vol.1 , pp. 323-333
    • Harris, K.S.1    Hellen, C.U.T.2    Wimmer, E.3
  • 9
    • 0025011840 scopus 로고
    • Proteolytic processing of picornaviral polyprotein
    • Palmenberg A.C. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol 1990, 44:603-623.
    • (1990) Annu Rev Microbiol , vol.44 , pp. 603-623
    • Palmenberg, A.C.1
  • 10
    • 0000327130 scopus 로고    scopus 로고
    • Picornaviridae: the viruses and their replication
    • Rueckert R.R. Picornaviridae: the viruses and their replication. Fields virology 1996, pp. 609-54. third ed.
    • (1996) Fields virology , pp. 609-54
    • Rueckert, R.R.1
  • 11
    • 0028179348 scopus 로고
    • Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides
    • Haarmann C.M., Schwimmbeck P.L., Mertens T., Schultheiss H.P., Strauer B.E. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 1994, 200:381-389.
    • (1994) Virology , vol.200 , pp. 381-389
    • Haarmann, C.M.1    Schwimmbeck, P.L.2    Mertens, T.3    Schultheiss, H.P.4    Strauer, B.E.5
  • 13
    • 0025249934 scopus 로고
    • Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects
    • Beck M.A., Chapman N.M., McManus B.M., Mullican J.C., Tracy S. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 1990, 136:669-681.
    • (1990) Am J Pathol , vol.136 , pp. 669-681
    • Beck, M.A.1    Chapman, N.M.2    McManus, B.M.3    Mullican, J.C.4    Tracy, S.5
  • 14
    • 0034003423 scopus 로고    scopus 로고
    • A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice
    • Chapman N.M., Ragland A., Leser J.S., Höfling K., Willian S., Semler B.L., et al. A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 2000, 74:4047-4056.
    • (2000) J Virol , vol.74 , pp. 4047-4056
    • Chapman, N.M.1    Ragland, A.2    Leser, J.S.3    Höfling, K.4    Willian, S.5    Semler, B.L.6
  • 15
    • 0025105736 scopus 로고
    • Vaccination of Balb/c mice against enteroviral mediated myocarditis
    • Fohlman J., Ilbäck N.G., Friman G., Morein B. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 1990, 8:381-384.
    • (1990) Vaccine , vol.8 , pp. 381-384
    • Fohlman, J.1    Ilbäck, N.G.2    Friman, G.3    Morein, B.4
  • 16
    • 0028561964 scopus 로고
    • Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses
    • See D.M., Tilles J.G. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses. Scand J Infect Dis 1994, 26:739-747.
    • (1994) Scand J Infect Dis , vol.26 , pp. 739-747
    • See, D.M.1    Tilles, J.G.2
  • 17
    • 0030984921 scopus 로고    scopus 로고
    • Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain
    • Zhang H., Morgan-Capner P., Latif N., Pandolfino Y.A., Fan W., Dunn M.J., et al. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am J Pathol 1997, 150:2197-2207.
    • (1997) Am J Pathol , vol.150 , pp. 2197-2207
    • Zhang, H.1    Morgan-Capner, P.2    Latif, N.3    Pandolfino, Y.A.4    Fan, W.5    Dunn, M.J.6
  • 18
    • 4143071461 scopus 로고    scopus 로고
    • Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection
    • Xu W., Shen Y., Jiang Z., Wang Y., Chu Y., Xiong S. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Vaccine 2004, 22:3603-3612.
    • (2004) Vaccine , vol.22 , pp. 3603-3612
    • Xu, W.1    Shen, Y.2    Jiang, Z.3    Wang, Y.4    Chu, Y.5    Xiong, S.6
  • 20
    • 0035852349 scopus 로고    scopus 로고
    • Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
    • Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
    • (2001) Vaccine , vol.20 , pp. 895-904
    • Wu, C.N.1    Lin, Y.C.2    Fann, C.3    Liao, N.S.4    Shih, S.R.5    Ho, M.S.6
  • 21
    • 0042825878 scopus 로고    scopus 로고
    • Virus-like particles as immunogens
    • Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol 2003, 11:438-444.
    • (2003) Trends Microbiol , vol.11 , pp. 438-444
    • Noad, R.1    Roy, P.2
  • 22
    • 33748794562 scopus 로고    scopus 로고
    • Virus-like particles: passport to immune recognition
    • Grgacic E.V.L., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
    • (2006) Methods , vol.40 , pp. 60-65
    • Grgacic, E.V.L.1    Anderson, D.A.2
  • 24
    • 0030764123 scopus 로고    scopus 로고
    • Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae
    • Rombaut B., Jore J.P. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae. J Gen Virol 1997, 78(Pt 8):1829-1832.
    • (1997) J Gen Virol , vol.78 , Issue.PART 8 , pp. 1829-1832
    • Rombaut, B.1    Jore, J.P.2
  • 25
    • 40849137446 scopus 로고    scopus 로고
    • Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge
    • Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
    • (2008) Vaccine , vol.26 , pp. 1855-1862
    • Chung, Y.-C.1    Ho, M.-S.2    Wu, J.-C.3    Chen, W.-J.4    Huang, J.-H.5    Chou, S.-T.6
  • 26
    • 77952314452 scopus 로고    scopus 로고
    • Introduction. The human papillomavirus VLP vaccines
    • Stanley M. Introduction. The human papillomavirus VLP vaccines. Gynecol Oncol 2010, 118:S1.
    • (2010) Gynecol Oncol , vol.118
    • Stanley, M.1
  • 28
    • 79953104927 scopus 로고    scopus 로고
    • Prevention of cancer by prophylactic human papillomavirus vaccines
    • Kwak K., Yemelyanova A., Roden R.B.S. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol 2011, 23:244-251.
    • (2011) Curr Opin Immunol , vol.23 , pp. 244-251
    • Kwak, K.1    Yemelyanova, A.2    Roden, R.B.S.3
  • 29
    • 0027368217 scopus 로고
    • Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants
    • Zhang H.Y., Yousef G.E., Cunningham L., Blake N.W., OuYang X., Bayston T.A., et al. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants. J Med Virol 1993, 41:129-137.
    • (1993) J Med Virol , vol.41 , pp. 129-137
    • Zhang, H.Y.1    Yousef, G.E.2    Cunningham, L.3    Blake, N.W.4    OuYang, X.5    Bayston, T.A.6
  • 30
    • 0027185673 scopus 로고
    • Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein
    • Bräutigam S., Snezhkov E., Bishop D.H. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Virology 1993, 192:512-524.
    • (1993) Virology , vol.192 , pp. 512-524
    • Bräutigam, S.1    Snezhkov, E.2    Bishop, D.H.3
  • 32
    • 0019806848 scopus 로고
    • Comparison of capsid polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells
    • Chatterjee N.K., Tuchowski C. Comparison of capsid polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells. Arch Virol 1981, 70:255-269.
    • (1981) Arch Virol , vol.70 , pp. 255-269
    • Chatterjee, N.K.1    Tuchowski, C.2
  • 33
    • 0020662357 scopus 로고
    • Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants
    • Gauntt C.J., Trousdale M.D., Lee J.C., Paque R.E. Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants. J Virol 1983, 45:1037-1047.
    • (1983) J Virol , vol.45 , pp. 1037-1047
    • Gauntt, C.J.1    Trousdale, M.D.2    Lee, J.C.3    Paque, R.E.4
  • 34
    • 84862818968 scopus 로고    scopus 로고
    • Baculovirus_vector_system_manual.
    • Baculovirus_vector_system_manual. http://www.bdbiosciences.com/documents/Baculovirus_vector_system_manual.pdf.
  • 35
    • 69849107576 scopus 로고    scopus 로고
    • Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli
    • Lee C.-D., Yan Y.-P., Liang S.-M., Wang T.-F. Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. J Biomed Sci 2009, 16:69.
    • (2009) J Biomed Sci , vol.16 , pp. 69
    • Lee, C.-D.1    Yan, Y.-P.2    Liang, S.-M.3    Wang, T.-F.4
  • 36
    • 1842298735 scopus 로고    scopus 로고
    • Expression and self-assembly of empty virus-like particles of hepatitis E virus
    • Li T.C., Yamakawa Y., Suzuki K., Tatsumi M., Razak M.A., Uchida T., et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997, 71:7207-7213.
    • (1997) J Virol , vol.71 , pp. 7207-7213
    • Li, T.C.1    Yamakawa, Y.2    Suzuki, K.3    Tatsumi, M.4    Razak, M.A.5    Uchida, T.6
  • 37
    • 57149121466 scopus 로고    scopus 로고
    • Expression of the Hepatitis A virus empty capsids in suspension cells and transgenic tobacco plants (Nicotiana tabacum L.)
    • Lopez A., Roasbal Y., Hernandez A., Gonzalez B., Rios J., Perez M., et al. Expression of the Hepatitis A virus empty capsids in suspension cells and transgenic tobacco plants (Nicotiana tabacum L.). Biotechnologia Aplicada 2008, 25:42-46.
    • (2008) Biotechnologia Aplicada , vol.25 , pp. 42-46
    • Lopez, A.1    Roasbal, Y.2    Hernandez, A.3    Gonzalez, B.4    Rios, J.5    Perez, M.6
  • 38
    • 33947609904 scopus 로고    scopus 로고
    • Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus
    • Zhang Y.-L., Guo Y.-J., Wang K.-Y., Lu K., Li K., Zhu Y., et al. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 2007, 65:320-328.
    • (2007) Scand J Immunol , vol.65 , pp. 320-328
    • Zhang, Y.-L.1    Guo, Y.-J.2    Wang, K.-Y.3    Lu, K.4    Li, K.5    Zhu, Y.6
  • 39
    • 0035858098 scopus 로고    scopus 로고
    • Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice
    • Li T.-C., Takeda N., Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001, 19:3476-3484.
    • (2001) Vaccine , vol.19 , pp. 3476-3484
    • Li, T.-C.1    Takeda, N.2    Miyamura, T.3
  • 40
    • 0344234364 scopus 로고    scopus 로고
    • Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles
    • Li T.-C., Suzaki Y., Ami Y., Dhole T.N., Miyamura T., Takeda N. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 2004, 22:370-377.
    • (2004) Vaccine , vol.22 , pp. 370-377
    • Li, T.-C.1    Suzaki, Y.2    Ami, Y.3    Dhole, T.N.4    Miyamura, T.5    Takeda, N.6
  • 41
    • 60149087397 scopus 로고    scopus 로고
    • The expression, purification, and immunogenicity of a new chimeric virus-like particle
    • Kui X., Sun M., Xie T., Wang W., Jiang L., Yan M., et al. The expression, purification, and immunogenicity of a new chimeric virus-like particle. Viral Immunol 2009, 22:49-56.
    • (2009) Viral Immunol , vol.22 , pp. 49-56
    • Kui, X.1    Sun, M.2    Xie, T.3    Wang, W.4    Jiang, L.5    Yan, M.6
  • 42
    • 0024318344 scopus 로고
    • Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector
    • Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., et al. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol 1989, 70(Pt 6):1453-1463.
    • (1989) J Gen Virol , vol.70 , Issue.PART 6 , pp. 1453-1463
    • Urakawa, T.1    Ferguson, M.2    Minor, P.D.3    Cooper, J.4    Sullivan, M.5    Almond, J.W.6
  • 43
    • 79952060998 scopus 로고    scopus 로고
    • Advances in human papilloma virus vaccines: a patent review
    • Cho H.-J., Oh Y.-K., Kim Y.B. Advances in human papilloma virus vaccines: a patent review. Expert Opin Ther Pat 2011, 21:295-309.
    • (2011) Expert Opin Ther Pat , vol.21 , pp. 295-309
    • Cho, H.-J.1    Oh, Y.-K.2    Kim, Y.B.3
  • 44
    • 0028309443 scopus 로고
    • Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3
    • Zhang H., Yousef G.E., Ouyang X., Archard L.C. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3. Int J Exp Pathol 1994, 75:99-110.
    • (1994) Int J Exp Pathol , vol.75 , pp. 99-110
    • Zhang, H.1    Yousef, G.E.2    Ouyang, X.3    Archard, L.C.4
  • 45
    • 0028969648 scopus 로고
    • A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin
    • Geller T.J., Condie D. A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin. J Neurol Sci 1995, 129:131-133.
    • (1995) J Neurol Sci , vol.129 , pp. 131-133
    • Geller, T.J.1    Condie, D.2
  • 46
    • 0024603936 scopus 로고
    • Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia
    • Hertel N.T., Pedersen F.K., Heilmann C. Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia. Eur J Pediatr 1989, 148:642-643.
    • (1989) Eur J Pediatr , vol.148 , pp. 642-643
    • Hertel, N.T.1    Pedersen, F.K.2    Heilmann, C.3
  • 47
    • 0031688798 scopus 로고    scopus 로고
    • Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
    • Kew O.M., Sutter R.W., Nottay B.K., McDonough M.J., Prevots D.R., Quick L., et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998, 36:2893-2899.
    • (1998) J Clin Microbiol , vol.36 , pp. 2893-2899
    • Kew, O.M.1    Sutter, R.W.2    Nottay, B.K.3    McDonough, M.J.4    Prevots, D.R.5    Quick, L.6
  • 48
    • 0033773155 scopus 로고    scopus 로고
    • Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice
    • Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 2000, 7:523-528.
    • (2000) J Biomed Sci , vol.7 , pp. 523-528
    • Yu, C.K.1    Chen, C.C.2    Chen, C.L.3    Wang, J.R.4    Liu, C.C.5    Yan, J.J.6
  • 49
    • 18144371146 scopus 로고    scopus 로고
    • + cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio
    • + cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio. J Virol 2005, 79:5988-5995.
    • (2005) J Virol , vol.79 , pp. 5988-5995
    • Wahid, R.1    Cannon, M.J.2    Chow, M.3
  • 50
    • 45749156795 scopus 로고    scopus 로고
    • Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71
    • Foo D.G.W., Macary P.A., Alonso S., Poh C.L. Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71. Viral Immunol 2008, 21:215-224.
    • (2008) Viral Immunol , vol.21 , pp. 215-224
    • Foo, D.G.W.1    Macary, P.A.2    Alonso, S.3    Poh, C.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.